Finance

Roʻyxatlar
Istiqbol: 70.0% optimistik·20.0% pessimistik
Tahlilga kirish
ELV:NYSE
Elevance Health
425,27 US$
+0,70%
(+2,95) 1K
425,27 US$
0,00% (0,00)
Yopilgandan keyin
Savdolar yopilgan: 13-okt, 16:00:02 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
ELV tikeri uchun statistika yaratilmoqda...
Ochish
427,00 US$
Yuqori
433,89 US$
Past
420,99 US$
Bozor kapitali
91,54 mlrd
Oʻrtacha hajm
1,20 mln
Hajmi
1,84 mln
52 haftalik eng yuqori
436,24 US$
52 haftalik eng past
274,84 US$
Beta
0,70
Muomaladagi aksiyalar
216,87 mln
Xodimlar soni
97 ming
Ochish
427,00 US$
Yuqori
433,89 US$
Past
420,99 US$
Bozor kapitali
91,54 mlrd
Oʻrtacha hajm
1,20 mln
Hajmi
1,84 mln
52 haftalik eng yuqori
436,24 US$
52 haftalik eng past
274,84 US$
Beta
0,70
Muomaladagi aksiyalar
216,87 mln
Xodimlar soni
97 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans. Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing /Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States. Wikipedia
Elevance Health haqida
CEOGail Koziara Boudreaux
Xodimlar soni96,6 ming
Asos solingan1944
Bosh ofislarIndianapolis, Indiana, Amerika Qo‘shma Shtatlari
SektorHealth care provider
Analitik reytinglar
Oxirgi 3 oyda ELV aksiyalari boʻyicha reyting bergan 16 tahlilchi xulosasiga koʻra
Sotib olish
Sotib olish
9
Ushlab qolish
7
Sotish
0
12 oylik prognoz
Oxirgi 3 oyda ELV uchun 12 oylik narx maqsadlarini taklif qilgan 16 Wall Street tahlilchisi xulosasiga koʻra
Eng yuqori
Joriy 425,27 US$
488,00 US$ (+14,75%)
O‘rtacha
445,07 US$ (+4,66%)
Eng past
393,00 US$ (-7,59%)
Analitik
Tavsiya
Amal
Kutilayotgan narx
Prognoz
Sana
Jason Cassorla
Guggenheim
Buy
Reiterated
460,00 US$
+8,2%
10/12/2026
Andrew Mok CFA
Barclays
Buy
Maintained
469,00 US$
+10,3%
10/07/2026
Ben Hendrix
RBC Capital
Hold
Maintained
424,00 US$
-0,3%
10/07/2026
Lance Wilkes
Bernstein
Buy
Maintained
488,00 US$
+14,8%
10/05/2026
A.J. Rice
UBS
Buy
Maintained
460,00 US$
+8,2%
09/18/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
473,00 US$
+11,2%
09/15/2026
Kevin Fischbeck
Bank of America Securities
Buy
Maintained
480,00 US$
+12,9%
09/11/2026
David Toung
Argus Research
Hold
Maintained
-
-
08/20/2026
Whit Mayo
Leerink Partners
Hold
Reiterated
395,00 US$
-7,1%
07/17/2026
Ryan Langston
TD Cowen
Buy
Reiterated
465,00 US$
+9,3%
07/17/2026
David Windley
Jefferies
Buy
Maintained
450,00 US$
+5,8%
07/16/2026
Scott Fidel
Goldman Sachs
Hold
Maintained
395,00 US$
-7,1%
07/15/2026
Erin Wright
Morgan Stanley
Hold
Reiterated
404,00 US$
-5%
07/17/2026
Michael Ha
Robert W. Baird
Hold
Maintained
393,00 US$
-7,6%
07/16/2026
Amit Daryanani
Evercore ISI
Hold
Maintained
-
-
07/15/2026
David S Macdonald
Truist Financial
Buy
Reiterated
475,00 US$
+11,7%
07/16/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
470,00 US$
+10,5%
07/13/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
450,00 US$
+5,8%
07/07/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
476,00 US$
+11,9%
06/08/2026
George Hill
Deutsche Bank
Buy
Upgraded
498,00 US$
+17,1%
05/20/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Upgraded
360,00 US$
-15,3%
05/19/2026
Keyingi hisobot: 8 kundan keyin
Chor, 21-okt, 14:30
Moliya davri
Ch.3 2026
- / 4,69 US$
Taxminiy daromad (USD)
- / 49,16 mlrd
Q3 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha: kelgusi tushumlar
Oxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – USD
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
50,71 mlrd
49,75 mlrd
50,18 mlrd
50,47 mlrd
Sotilgan mahsulotning tannarxi
38,14 mlrd
38,06 mlrd
35,62 mlrd
37,02 mlrd
Daromad narxi
38,14 mlrd
38,06 mlrd
35,62 mlrd
37,02 mlrd
Tadqiqot va ishlanmalarga xarajatlar
-
-
-
-
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
10,65 mlrd
10,75 mlrd
11,79 mlrd
11,04 mlrd
Operatsion xarajatlar
10,81 mlrd
10,92 mlrd
11,90 mlrd
11,15 mlrd
Jami operatsion xarajatlar
48,95 mlrd
48,98 mlrd
47,52 mlrd
48,17 mlrd
Operatsion daromad
1,76 mlrd
766,00 mln
2,66 mlrd
2,30 mlrd
Boshqa nooperatsion daromad
-
-
-
-
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
1,41 mlrd
215,00 mln
2,30 mlrd
1,94 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
1,41 mlrd
399,00 mln
2,30 mlrd
1,94 mlrd
Daromad soligʻi boʻyicha xarajat
219,00 mln
-331,00 mln
544,00 mln
483,00 mln
Amaldagi soliq stavkasi
15,58%
-153,95%
23,61%
24,94%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
1,19 mlrd
547,00 mln
1,76 mlrd
1,46 mlrd
Sof foyda marjasi
2,34%
1,10%
3,52%
2,90%
Har bir aksiya foydasi
6,03
3,33
12,58
7,45
Foizlar va investitsiyalardan olingan daromadlar
-
-
-
-
Foizlarni toʻlash xarajatlari
-351,00 mln
-367,00 mln
-357,00 mln
-364,00 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-351,00 mln
-367,00 mln
-357,00 mln
-364,00 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
2,14 mlrd
1,17 mlrd
3,02 mlrd
2,67 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
Insayder tranzaksiyalari
Insayder tranzaksiyalari maʼlumotlari tashqi manbalardan olingan. Batafsil
Insayder
Joylashuvi
Turi
Sana
Aksiyalar
Miqdor
1-sahifa
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari